Intended for healthcare professionals


Beneficial effects of simvastatin may be due to non-lipid actions

BMJ 1995; 311 doi: (Published 25 November 1995) Cite this as: BMJ 1995;311:1436
  1. Uffe Ravnskov
  1. Specialist in internal medicine Rabygatan 2, S-223 61 Lund, Sweden

    EDITOR,--On the basis of new trial evidence Michael Oliver and colleagues claim that there is no longer any controversy about cholesterol lowering as secondary prevention of atherosclerosis and coronary heart disease.1 To reach this conclusion they have disregarded many conflicting findings.

    According to Oliver and colleagues, the first principle of the lipid hypothesis is the association between a raised plasma cholesterol concentration and risk of coronary heart disease. This association, however, has been found mainly in people without previous disease. A strong, graded, positive correlation has …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription